Clinical trials: in Uruguay

Colorectal Adenoma

Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)

• Completed
• Age: 30 years and older
• Phase 3

This study is a prospective, randomized, double-blind, placebo-controlled, multi-center trial to compare the efficacy and safety of celecoxib 400mg QD versus placebo in reducing the occurrence of new colorectal adenomas…

Trial name

PRESAP (NCT00141193)

Testing

Celecoxib

Where

106 sites in United States, Australia and 30 more

Volunteers

1,561 people

Sponsor

Pfizer